Biotech · Private company · Groton, CT, US
Oncoarendi Therapeutics, LLC
Track this companyFree. Adds Oncoarendi Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Myocardin-related transcription factor (MRTF) pathway modulators as a novel, disease-modifying oral medicine for idiopathic pulmonary fibrosis (IPF)Fiscal year 2025 · $66.5KNIH RePORTER 5R43HL174237-02 · fetched Nov 12, 2026
- Myocardin-related transcription factor (MRTF) pathway modulators as a novel, disease-modifying oral medicine for idiopathic pulmonary fibrosis (IPF)Fiscal year 2024 · $241.1KNIH RePORTER 1R43HL174237-01 · fetched Nov 12, 2026